Background-Microvascular function is increasingly being recognized as an important marker of risk in coronary artery disease, and may be accurately assessed by intracoronary Doppler flow velocity measurements. In the setting of STsegment-elevation myocardial infarction there are limited data regarding the prognostic value of microvascular function in both infarct-related and reference coronary arteries for long-term clinical outcome. We sought to determine the prognostic value of microvascular function, as assessed by Doppler flow velocity measurements, for cardiac mortality after primary percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction. Methods and Results-Between April 1997 and August 2000, we included 100 consecutive patients with a first anterior wall ST-segment-elevation myocardial infarction. Immediately after primary percutaneous coronary intervention, intracoronary Doppler flow velocity was measured in the infarct-related artery, to determine coronary flow velocity reserve (CFVR), diastolic deceleration time, and the presence of systolic retrograde flow, as well as in a reference vessel to determine reference vessel CFVR. The primary end point was cardiac mortality at 10-year follow-up. Complete follow-up was obtained in 94 patients (94%). At 10-year follow-up, cardiac mortality amounted to 14%. Cardiac mortality amounted to 5% when reference vessel CFVR was normal (≥2.1), in contrast to 31% when abnormal (<2.1; P=0.001). Reference vessel CFVR <2.1 was associated with a 4.09 increase in long-term cardiac mortality hazard after multivariate adjustment for identified predictors for cardiac mortality (hazard ratio, 4.09; 95% confidence interval, 1.18-14.17; P=0.03) Conclusions-Microvascular dysfunction, measured by reference vessel CFVR determined after primary percutaneous coronary intervention for acute anterior wall ST-segment-elevation myocardial infarction is associated with a significantly increased long-term cardiac mortality. (Circ Cardiovasc Interv. 2013;6:207-215.)
T imely mechanical reperfusion by means of primary percutaneous coronary intervention (PCI) is the optimal treatment strategy in ST-segment-elevation myocardial infarction (STEMI) patients. 1, 2 Primary PCI aims at immediate restoration of epicardial vessel patency and subsequent reperfusion of myocardial tissue. Inadequate myocardial reperfusion at the microvascular level is known to be associated with larger infarct size, lower residual left ventricular function, and increased mortality at follow-up. [3] [4] [5] [6] [7] [8] Although epicardial vessel patency is restored successfully in most primary PCI procedures, microvascular reperfusion can be inadequate even when optimal angiographic epicardial reperfusion is achieved. 9, 10 Intracoronary-derived Doppler flow velocity measurements allow sensitive assessment of microvascular function in clinical practice. 9, 11 The Doppler flow velocity-derived parameters coronary flow velocity reserve (CFVR), diastolic deceleration time (DDT), and early systolic retrograde flow (SRF) in the infarct-related coronary artery were shown to correspond to the extent of microvascular dysfunction after reperfusion for STEMI. 12 Moreover, several studies have indicated that CFVR in the infarct-related artery assessed after primary PCI is the most valuable prognostic marker of recovery of left ventricular function after STEMI. 7, 8, [13] [14] [15] [16] [17] prognostic value for long-term clinical outcome. Moreover, although microvascular alterations have additionally been reported to occur at a distance from the infarcted myocardium, the prognostic value of microvascular function in a reference vessel for long-term clinical outcome after mechanical reperfusion for STEMI has not been investigated. 20 We hypothesize that microvascular function, as assessed by means of Doppler flow velocity measurement, plays an important role in long-term clinical outcome after primary PCI for STEMI. Therefore, we sought to determine the prognostic value for long-term cardiac mortality of microvascular function, as assessed by Doppler flow velocity measurement, in infarct-related as well as reference coronary arteries after primary PCI for STEMI.
Methods

Data Source and Patient Selection
Between April 1997 and August 2000, 100 consecutive patients with a first anterior wall STEMI treated by primary PCI were enrolled in the study, for whom the initial results have been reported previously. 8, 20 All patients were treated in the Academic Medical Center in Amsterdam, a large tertiary referral center in Amsterdam, The Netherlands.
Anterior STEMI was defined as chest pain lasting >30 minutes in the presence of persistent ST-segment elevation in ≥2 precordial leads. Primary PCI was performed within 6 hours after the onset of symptoms according to standard clinical practice, with provisional bare metal stent implantation. Major exclusion criteria comprised prior anterior wall myocardial infarction (MI), acute left-side heart failure (Killip class >II), prior coronary artery bypass grafting, known left ventricular ejection fraction of <40%, left ventricular hypertrophy, absence of thoracic windows for echocardiography, 3-vessel coronary artery disease, Thrombolysis In Myocardial Infarction (TIMI) grade 2 or 3 flow at initial angiography before PCI, or unsuccessful PCI defined as TIMI grade 0 or 1 flow or >50% residual stenosis in the infarct-related artery after PCI. The study protocol was approved by the local ethics committee and all patients gave informed consent.
Periprocedural Measurements
Intracoronary blood flow velocity in the infarct-related coronary artery was measured 5 to 10 minutes after successful PCI using a 0.014-inch Doppler-sensor equipped guidewire (Volcano Corp., San Diego, CA). CFVR was defined as the ratio of hyperemic average peak flow velocity (APV) to baseline APV. Doppler flow velocity was additionally assessed in an angiographic normal reference coronary artery, defined as a coronary artery with <30% diameter stenosis on visual estimation. Reference vessel measurements were performed in the left circumflex coronary artery, unless a stenosis of >30% was present, in which case the right coronary artery was used. Hyperemia was induced by an intracoronary bolus of adenosine (20-40 µg) . The Doppler flow velocity signal was analyzed offline to evaluate DDT and the presence of SRF in the infarct-related artery. Before and after PCI, coronary angiography suitable for quantitative coronary angiographic analysis was performed for offline analysis of TIMI flow 21 and myocardial blush grade. 6 Left ventricular function was evaluated by means of echocardiographic 16-segment Wall Motion Score Index (WMSI) performed immediately before primary PCI. 8 At 6-month follow-up, echocardiographic evaluation of left ventricular function was repeated, and patients underwent repeat angiography with assessment of intracoronary Doppler flow velocity, the initial results of which have been reported previously. 8, 20 
Long-term Follow-up
Long-term follow-up regarding the occurrence of death was collected by identifying patients in the Dutch national population registry. The cause of death was verified by evaluating hospital records, or contacting the general practitioner. Death was considered cardiac unless an unequivocal noncardiac cause could be established. 22
Statistical Analysis
To analyze the relationship between cardiac death and CFVR in the infarct-related or reference vessel, we performed 3 sequential analyses. First, we determined the optimal cut-off value for cardiac mortality of CFVR in both vessels using receiver-operator-characteristics curves. The cut-off values with the highest sum of sensitivity and specificity were used for subsequent analyses. Second, the Kaplan-Meier method was used to estimate cumulative cardiac mortality rates according to the previously identified cut-off values, which were compared by means of the log-rank test. Third, the prognostic value of CFVR in the infarctrelated and in the reference vessel was evaluated in 2 sets of Cox proportional hazards models. An univariable model was used to identify variables significantly associated with cardiac mortality. Subsequent multivariable analysis was performed using a stepwise Cox proportional hazards model with adjustments for these variables (P<0.1), and including adjustments for age. Data are presented as mean (±SD), frequency (percentage), or median (25th-75th percentile). Student t test, Mann-Whitney U Test, χ 2 , or Fisher exact test was used, when appropriate, to test for differences between groups. Event rates are reported as 10-year Kaplan-Meier estimates of cumulative cardiac mortality. A 2-sided α-level of 0.05 was considered statistically significant.
Results
Study Population Characteristics
Complete follow-up was obtained in 94 of the 100 patients (94%). Baseline characteristics of these patients are shown in Table 1 .
At the end of the procedure, TIMI 3 flow was achieved in the infarct-related artery in 70 patients (75%), and myocardial blush grade 3 was achieved in 50 patients (52%). Mean CFVR in the infarct-related artery was 1.6±0.4 (median, 1.5; 25th-75th percentile 1.3-1.8) in contrast to 2.4±0.5 (median, 2.3; 25th-75th percentile 2.0-2.7) in the reference vessel (left circumflex coronary artery in 84 patients [89%]; right coronary artery in 10 patients [11%]). A rapid DDT, defined as DDT <600 ms, was found in 49 patients (52%), and SRF was present in 27 patients (29%).
WHAT IS KNOWN
• Microvascular function is increasingly recognized as an important marker of risk in coronary artery disease, and may be accurately assessed invasively by intracoronary Doppler flow velocity measurements.
• Microvascular function assessed by Doppler flow velocity is altered in the setting of ST-segment-elevation myocardial infarction, even in nonischemic regions remote from the infarcted myocardial tissue.
• Coronary flow velocity reserve in a reference vessel is a more selective marker of general microvascular function.
WHAT THE STUDY ADDS
• Impaired coronary flow velocity reserve in a reference vessel is independently associated with an increased risk for long-term fatal cardiac events.
During a median follow-up of 11.0 years (interquartile range, 10.0-12.1 years) 18% of patients died (17 of 94), whereas 16% (15 of 94) of patients died of a cardiac cause. The 10-year Kaplan-Meier estimate of cumulative all-cause mortality was 15%, and amounted to 14% for cardiac mortality.
Flow Velocity Parameters and Long-term Cardiac Mortality
The optimal identified cut-off values were 2.1 for CFVR in the reference vessel (sensitivity 73%, specificity 71%), and 1.5 for CFVR in the infarct-related artery (sensitivity 73%, specificity 62%).
Ten-year estimates of cardiac mortality differed significantly between high and low reference vessel CFVR groups, and amounted to 5% in patients with high reference vessel CFVR values, compared with 31% in patients with low reference vessel CFVR values (P=0.001; Figure A) . In contrast, 10-year estimates of cardiac mortality amounted to 9% and 20% in patients with high and low infarct-related artery CFVR values, respectively, which was not significantly different between groups (P=0.10; Figure B ). In bivariate analysis, a reference vessel CFVR of <2.1 was associated with a 3.67-fold increase in long-term cardiac mortality hazard (hazard ratio [HR], 3.67; 95% confidence interval, 1.19-11.37; P=0.02; Table 2 ). Contrariwise, a target vessel CFVR of <1.5 was not associated with an increase in long-term cardiac mortality hazard (HR, 1.67; 95% confidence interval, 0.56-4.98; P=0. 36 ). There was no significant difference in cardiac mortality rates between patients with and without a rapid DDT or SRF in the infarct-related artery (log-rank P=0.42 and P=0.23, respectively).
Clinical and Procedural Characteristics According to Reference Vessel CFVR and Extent of Myocardial Infarction
Differences in clinical and procedural characteristics between the 2 reference vessel CFVR groups are shown in Table 3 , which includes known prognostic factors for mortality in STEMI patients. [23] [24] [25] Notably, the impairment in reference vessel CFVR resulted primarily from a low hyperemic APV in the presence of high hyperemic microvascular resistance, in combination with a high baseline APV in the presence of a low baseline microvascular resistance in patients with an abnormal reference vessel CFVR (Table 3) .
We additionally evaluated differences in clinical and procedural characteristics, as well as flow velocity parameters stratified according to the extent of infarction discriminated by the median peak creatine kinase myocardial band isoenzyme level (Appendix in the online-only Data Supplement). No clinically pertinent differences in clinical or procedural characteristics were found between patients with small (peak creatine kinase myocardial band isoenzyme <471 µg/L) or large (peak creatine kinase myocardial band isoenzyme ≥471 µg/L) MIs. Patients with large MI had a significantly higher WMSI, but no differences in infarct-related artery or reference vessel CFVR were found between groups. Although reference vessel baseline APV was significantly higher in patients with large MI (16±4 cm/s versus 18±6 cm/s, respectively; P=0.03), this difference was eclipsed by a numerically equivalent, but not statistically significant, difference in hyperemic APV (38±9 cm/s versus 41±14 cm/s, respectively; P=0.34), resulting in equal reference vessel CFVR between these groups (2.5±0.5 versus 2.3±0.6, respectively; P=0.09).
Association Between Impaired Reference Vessel CFVR and Long-term Cardiac Mortality
Univariable analyses of all candidate covariates as listed in Table 3 showed that reference vessel CFVR <2.1 at the end of the procedure, history of hypertension, age ≥65 years, increasing N-terminal probrain natriuretic peptide levels assessed after reperfusion, as well as TIMI flow grade <3 at the end of the procedure as were associated with cardiac mortality at long-term follow-up (Table 4 ). After adjustment for these variables, a reference vessel CFVR of <2.1 was associated with a 4.09-fold increase in long-term cardiac mortality hazard (HR, 4.09; 95% confidence interval, 1.18-14.17; P=0.03).
Ventricular Function and CFVR at 6-Month Follow-up and Long-term Cardiac Mortality
Six-month follow-up WMSI and intracoronary measurements were available in 71 patients (Table 5 ). 20 At 6-month follow-up, there was a numerically small, but statistically significant difference in left ventricular function between both reference vessel CFVR groups, as assessed by WMSI (Table 5 ). Importantly, WMSI at 6-month follow-up was not associated with an increase in cardiac mortality hazard at long-term follow-up (HR, 5.49; 95% confidence interval, 0.59-50.75; P=0.13). CFVR in both the target, as well as the reference vessel remained lower within those patients with low reference vessel CFVR after reperfusion during the index procedure (Table 5 ). Notably, in contrast with the findings directly after reperfusion, the impairment of CFVR in both infarct-related, as well as reference coronary arteries at 6-month follow-up resulted from a significantly higher 
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baseline APV in the presence of a significantly lower baseline microvascular resistance in patients with impaired CFVR. Contrariwise, hyperemic APV, in concordance with hyperemic microvascular resistance, did not differ between groups ( 
Discussion
We have previously reported that microvascular function assessed by Doppler flow velocity is altered in the setting of STEMI, even in nonischemic regions at distance from the infarcted myocardial tissue. 20 This has also been observed in experimental studies, and studies using noninvasive imaging modalities. [28] [29] [30] The present study is the first to indicate that this altered microvascular function at regions remote from the infarct-related artery is independently associated with longterm fatal cardiac events. We observed that an impaired CFVR in a reference coronary artery, determined after primary PCI for a first anterior wall STEMI, is associated with a 4.09-fold increase in longterm cardiac mortality hazard. The 10-year Kaplan-Meier estimate of cardiac mortality amounted to 5% when reference CFVR was normal and to 31% when reference vessel CFVR was abnormal. Contrariwise, impaired CFVR measured in the infarct-related artery was not significantly associated with long-term cardiac mortality in the present data set. The acute impairment of reference vessel CFVR followed from a predominant decrease in hyperemic APV in the presence of an increased hyperemic microvascular resistance, in combination with a less pronounced increase in baseline APV in the Values are presented as frequency (%), mean±SD or median (25th-75th percentile). APV indicates average peak flow velocity; CFVR, coronary flow velocity reserve; CK-MB, creatine kinase myocardial band isoenzyme; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; IRA, infarct-related artery; MR, microvascular resistance; NT-proBNP, N-terminal probrain natriuretic peptide; TIMI, Thrombolysis In Myocardial Infarction; and WMSI, Wall Motion Score Index.
presence of a decreased baseline microvascular resistance. Persistent impairment of reference vessel CFVR at 6-month follow-up resulted from a high baseline APV, in the presence of a low baseline microvascular resistance, and was associated with a 10.7-fold increase in cardiac mortality hazard during subsequent follow-up.
Previous Studies Regarding Impaired Infarct-Related Artery CFVR and Long-term Clinical Outcome
Two studies have previously reported on the prognostic value of CFVR in the infarct-related artery. Furber et al 31 described, for the first time, that Doppler flow velocity parameters in the infarct-related artery are of prognostic value for long-term cardiac events. In their study of 68 patients with a first acute MI, a short DDT in the infarct-related artery, as a parameter for impaired microvascular perfusion, was found to identify patients at high risk for cardiac events, with heart failure as the predominating cardiac event. Short DDT specifically identified those patients at risk for early occurrence of heart failure. This early differentiation in risk persisted during ≈4 years of follow-up. Additionally, a study by Takahashi et al 13 evaluated the prognostic value of CFVR in the infarct-related artery on long-term cardiac events in 118 patients after primary PCI for a first anterior acute MI. They found an impaired CFVR in the infarct-related artery to be significantly associated with increased cardiac event rates at a mean of 5.2±2.7 years of follow-up. Again, impaired CFVR in the infarct-related artery was primarily shown to identify those patients at risk for early occurrence of heart failure. These studies are therefore consistent with the earlier observation that Doppler flow velocity parameters harbor accurate prognostic information on the recovery of left ventricular function. 7, 8, [13] [14] [15] [16] [17] 
Coronary Flow Velocity Reserve and Long-term Fatal Cardiac Events
In our study, in which we focused on cardiac mortality only, we found an unequivocal relationship between impaired microvascular function in a reference coronary artery and long-term fatal cardiac events, independent of left ventricular function. CFVR, the presence of SRF, or rapid DDT in the infarctrelated artery did not identify individual patients at high risk for cardiac mortality at long-term follow-up. However, CFVR in the infarct-related artery was associated with a high risk for early cardiac mortality, which dissipated over time. In bivariate analysis with reference vessel CFVR, the marginal association of infarct-related artery CFVR with long-term cardiac Values are presented as frequency (%), mean±SD or median (25th-75th percentile). APV indicates average peak flow velocity; CFVR, coronary flow velocity reserve; IRA, infarct-related artery; MR, microvascular resistance; and WMSI, Wall Motion Score Index. mortality was eclipsed by the hazard inherited by impairment of reference vessel CFVR. Intuitively, the physiological alterations in the myocardium because of the acute ischemic event are more pronounced in the infarct-related artery, than in regions more remote from the infarction. The information on the microvascular status derived from CFVR in the infarct-related artery is obscured by the impact of acute and continuous ischemia, and the possible detrimental effects of reperfusion on myocardial tissue. In contrast, reference vessel CFVR provides information on the general functional status of the microvasculature after the acute ischemic event. Reference vessel CFVR may therefore be considered a more selective marker of microvascular function, which apparently plays a pivotal role in long-term outcome after STEMI.
Cause of Impaired Reference Vessel Coronary Flow Velocity Reserve After STEMI
During acute regional ischemia, several factors have been shown to impair CFVR in regions remote from the infarction. First, the regional dysfunction of the ischemic myocardium leads to a compensatory hyperkinesis of remote nonischemic myocardium. 32, 33 This was reported to result in an impaired reference vessel CFVR because of a predominant increase in baseline flow velocity. 28, 32, 34 Second, apart from the systolic mechanical interaction between the myocardium and the coronary microvasculature, cardiac mechanics exert their effect also during diastole. 35 A restriction in myocardial capacitance, which may result from either an increase in left ventricular end-diastolic pressure (LVEDP), or stiffening of the myocardium because of hypoxic perfusion in the absence of an increased LVEDP, 36 limits coronary flow during late diastole. This is expresses as an isolated decrease in hyperemic APV in the infarct-related artery and as an isolated increase in baseline APV in the reference vessel, resulting in a lower CFVR in both territories. 37 Third, neurohumoral activation in response to the acute ischemic event interferes with the reactivity of the coronary resistance vessels in the infarct-related as well as in remote regions. The rigorous and persistent activation of the sympathetic nervous system 38, 39 results in activation of coronary vascular α-adrenoceptors by neuronal and humoral cathecholamines, 40 and induces a paradoxical vasoconstriction in times of increased myocardial oxygen demand. 41 Although metabolic vasodilation prevails in such a situation, α-adrenergic vasoconstriction competes, resulting in a decrease in hyperemic flow velocity, limiting CFVR throughout the heart. 42, 43 Finally, impaired reference vessel CFVR, associated with a low baseline microvascular resistance, was shown to be of important prognostic value in patients with stable coronary artery disease, in the absence of mechanical myocardial dysfunction, and in the absence of an acute ischemic event. 44 This finding indicates that pre-existent microvascular dysfunction may play an important role in long-term clinical outcome.
Overall, mechanical factors induced by the acute ischemic event, as well as pre-existent microvascular alterations are primarily expressed as an increase in baseline flow velocity. Neurohumoral activation, however, results in an increase in reference vessel hyperemic microvascular resistance, resulting in a decrease in maximal hyperemic flow velocity. Both causes may thereby result in an impaired reference vessel CFVR.
Implications for the Present Study
We observed that an impaired reference vessel CFVR at the time of STEMI results predominantly from a low APV during the hyperemic response to an intracoronary bolus of adenosine, together with a less pronounced increase in baseline APV (Table 3) . 20 Because compensatory hyperkinesis in the remote regions is associated with a predominant increase in baseline flow velocity, 28, 32 compensatory hyperkinesis as the sole cause for the impaired reference vessel CFVR is unlikely. Additionally, although LVEDP was not measured in the present study, our study excluded patients with Killip class >2, and the study population consisted of patients in a hemodynamically stable state without known structural heart disease, in whom increase in LVEDP can be expected to be limited. Nonetheless, stiffening of the myocardium because of hypoxic perfusion cannot be excluded, and may explain part of the increase in baseline flow velocity in the reference coronary artery because of a decrease in myocardial capacitance in this setting of anterior wall STEMI. Moreover, although we have no information on pre-existent microvascular dysfunction in our study population, pre-existent dysfunction would have accounted for a predominant decrease in baseline microvascular resistance. In accordance with previous reports, 29, 30 the combination of observations in the present study implies that reference vessel CFVR in the setting of STEMI summarizes a complicated interrelation between neurohumoral overactivation induced by the acute ischemic event, pre-existent microvascular dysfunction, or the acute regional and global mechanical myocardial disruption, but is predominantly determined by the neurohumoral overactivation, which accounts for an immediate high risk for fatal cardiac events.
Reference Vessel CFVR at 6-Month Follow-up and Long-term Cardiac Mortality
In contrast to the findings in the acute setting, we observed that an impaired reference vessel CFVR at 6-month followup originated from a persistently higher baseline APV in conjunction with a lower baseline microvascular resistance, in the presence of restored minimal hyperemic microvascular resistance. This may result from pre-existent microvascular dysfunction, as was found in patients with stable coronary artery disease and after PCI, 45 or possibly from ongoing microvascular adaptation compensatory to the alterations in myocardial workload because of the loss of functioning myocardium, both of which may be responsible for a high risk for fatal cardiac events during subsequent follow-up.
Study Limitations
Assessment of intracoronary blood flow velocity is a technique that is sensitive for technical failures, and accurate evaluation of CFVR is dependent on the experience of the cardiologist. All coronary flow velocity measurements in this study were performed by operators with ample experience in intracoronary flow velocity measurements. Accurate assessment of flow velocity depends furthermore on the achievement of maximal vasodilation. Although there has been an extensive debate on the amount of adenosine needed to achieve a maximally vasodilated state, the amount of adenosine used in this study is considered sufficient. 46 The study protocol excluded patients with signs of acute left-sided heart failure. We felt that patients in such critical condition were not suited to undergo the extensive measurement protocol. Moreover, exclusion of these patients was motivated by the anticipated effect of a high LVEDP in the acute phase of heart failure on coronary flow velocity parameters. However, concomitantly, large MIs have been excluded from evaluation in this study; as a consequence, our observations are only valid in the context of acute anterior wall MI not complicated by acute left-sided heart failure.
In the absence of an established cut-off value, the optimal cut-off values of target vessel and reference vessel CFVR for long-term cardiac mortality were derived from the present data set. The evaluation of the relationship between CFVR at these cut-off values and long-term clinical outcome within the same data set may provide an advantageous estimate of the relationship, and should be confirmed in further studies.
Additionally, the study population was small, in particular at 6-month follow-up, and some predictors of long-term outcome may have been missed because of a lack of statistical power. Consequently, although our results are indicative for a strong prognostic value of CFVR in a reference vessel for long-term cardiac mortality, these results should be considered hypothesis generating, and should be confirmed in further studies. Moreover, in addition to the possible obscuring effect of the acute event on the association of target vessel CFVR with long-term outcome, the small sample size may in in part explain the lack of a statistically significant association between target vessel CFVR and long-term cardiac mortality.
Conclusions
We conclude that microvascular function, as assessed by the coronary vasodilator reserve in a reference vessel, plays a pivotal role in long-term cardiac mortality after primary PCI for STEMI.
